MarketCap
Processa Pharmaceuticals PCSA
$ 1.93
3.76%
Facebook
X
Telegram
Processa Pharmaceuticals PEG Ratio | PCSA
Annual PEG Ratio Processa Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.000309 | -0.000032 | -0.000344 | -0.000016 | -0.178 | 0.00897 | -95 K | 0.476 | -1.01 | -0.0548 | -0.0241 | 0.367 | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.476 | -95 K | -7.92 K |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
CollPlant Biotechnologies Ltd.
CLGN
|
0.00102 | $ 3.94 | 2.79 % | $ 48.1 M |  Israel |
 |
Edesa Biotech
EDSA
|
-0.0227 | $ 2.19 | 2.67 % | $ 12.4 M |  USA |
 |
Bristol-Myers Squibb Company
BMY
|
-1.57 | $ 62.15 | -1.6 % | $ 126 B | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-0.471 | $ 14.49 | 4.4 % | $ 937 M | USA |
 |
Moderna
MRNA
|
0.0169 | $ 253.93 | 5.17 % | $ 98.8 B | USA |
 |
XTL Biopharmaceuticals Ltd.
XTLB
|
-80 | $ 1.55 | -9.36 % | $ 1.04 B | Israel |
 |
Achieve Life Sciences
ACHV
|
0.0771 | $ 6.75 | 5.8 % | $ 294 M | USA |
 |
Amgen
AMGN
|
5.35 | $ 460.27 | 0.28 % | $ 248 B | USA |
 |
Armata Pharmaceuticals
ARMP
|
0.868 | $ 3.37 | 12.33 % | $ 122 M | USA |
 |
Axsome Therapeutics
AXSM
|
-5.2 | $ 132.34 | 1.95 % | $ 6.58 B | USA |
 |
Champions Oncology
CSBR
|
0.854 | $ 4.8 | 0.85 % | $ 66.4 M | USA |
|
Forte Biosciences
FBRX
|
-0.00934 | $ 76.99 | 0.03 % | $ 997 M | USA |
 |
Immunic
IMUX
|
0.0859 | $ 7.79 | 6.42 % | $ 1.21 B | USA |
 |
AC Immune SA
ACIU
|
2.39 | $ 2.23 | 5.69 % | $ 225 M |  Schweiz |
 |
Aldeyra Therapeutics
ALDX
|
1.65 | $ 0.64 | 4.12 % | $ 38.4 M | USA |
 |
Aptose Biosciences
APTO
|
-0.000164 | - | -45.71 % | $ 1.2 M |  Canada |
 |
Precision BioSciences
DTIL
|
-0.00214 | $ 10.62 | 7.6 % | $ 136 M | USA |
 |
AIM ImmunoTech
AIM
|
-0.000094 | $ 0.16 | 4.41 % | $ 259 K | USA |
 |
Ascendis Pharma A/S
ASND
|
4.41 | $ 256.91 | 1.37 % | $ 15.6 B |  Danmark |
 |
ANI Pharmaceuticals
ANIP
|
0.147 | $ 67.32 | -3.3 % | $ 1.35 B | USA |
 |
Actinium Pharmaceuticals
ATNM
|
0.175 | $ 1.42 | 9.23 % | $ 44.3 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
0.0594 | $ 1.29 | 2.38 % | $ 343 M |  Britain |
 |
BridgeBio Pharma
BBIO
|
2.48 | $ 74.28 | 0.01 % | $ 14.2 B | USA |
 |
BioCryst Pharmaceuticals
BCRX
|
-0.00258 | $ 7.69 | 0.72 % | $ 1.61 B | USA |
 |
Bicycle Therapeutics plc
BCYC
|
-0.167 | $ 3.6 | 3.45 % | $ 249 M | Britain |
 |
Coherus BioSciences
CHRS
|
-0.0207 | $ 0.77 | 2.9 % | $ 90.2 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
6.77 | $ 25.59 | -5.24 % | $ 3.26 B | USA |
 |
Cellectis S.A.
CLLS
|
0.221 | $ 1.09 | 5.83 % | $ 109 M |  France |
 |
BeyondSpring
BYSI
|
2.09 | $ 0.61 | -3.32 % | $ 25.1 M | USA |
 |
Alkermes plc
ALKS
|
-0.493 | $ 45.88 | 3.01 % | $ 7.56 B |  Irlanda |
 |
Altimmune
ALT
|
0.647 | $ 2.09 | 6.09 % | $ 184 M | USA |
 |
Cardiff Oncology
CRDF
|
185 | $ 0.8 | 5.3 % | $ 53.5 M | USA |
 |
Citius Pharmaceuticals
CTXR
|
-0.000437 | $ 0.55 | -1.2 % | $ 6.09 M | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
0.0261 | $ 10.35 | 10.52 % | $ 283 M | Israel |
 |
Arrowhead Pharmaceuticals
ARWR
|
-141 | $ 58.16 | 1.22 % | $ 7.78 B | USA |
 |
Incyte Corporation
INCY
|
0.135 | $ 119.79 | 1.51 % | $ 23.4 B | USA |
 |
Atara Biotherapeutics
ATRA
|
0.00555 | $ 7.81 | -1.88 % | $ 98 M | USA |
 |
Aurinia Pharmaceuticals
AUPH
|
0.357 | $ 16.32 | 0.68 % | $ 2.19 B | Canada |
 |
BioNTech SE
BNTX
|
0.00586 | $ 87.46 | 1.86 % | $ 21.1 B |  Germany |
 |
Collegium Pharmaceutical
COLL
|
0.288 | $ 24.19 | -3.86 % | $ 766 M | USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
-0.0104 | $ 3.07 | 7.34 % | $ 40.9 M | USA |
|
Enlivex Therapeutics Ltd.
ENLV
|
-0.041 | $ 1.26 | -0.79 % | $ 57.6 M | Israel |
 |
AnaptysBio
ANAB
|
0.374 | $ 46.46 | 1.92 % | $ 1.35 B | USA |
 |
Assembly Biosciences
ASMB
|
-0.453 | $ 20.43 | 2.17 % | $ 229 M | USA |
 |
Adagene
ADAG
|
0.612 | $ 1.99 | -1.73 % | $ 117 M |  China |
 |
Benitec Biopharma
BNTC
|
-0.0443 | $ 9.51 | 10.07 % | $ 443 M | USA |
 |
Denali Therapeutics
DNLI
|
0.0634 | $ 20.09 | 1.88 % | $ 3.47 B | USA |
 |
Amarin Corporation plc
AMRN
|
0.633 | $ 11.55 | -0.2 % | $ 4.79 B | Irlanda |
 |
Editas Medicine
EDIT
|
-1.63 | $ 2.57 | 0.59 % | $ 228 M | USA |